A CONTEMPORARY PERSPECTIVE ON POLYCYSTIC OVARIAN SYNDROME
Keywords:
Key words: hyperandrogenism, anovulation, infertility.Abstract
Annotation. The author of this article presents a modern understanding of the
problem of polycystic ovary syndrome (PCOS). PCOS is a multifactorial, genetically
determined pathological condition, in the pathogenesis of which an important role
belongs to disorders of gonadotropic regulation, hyperandrogenism, insulin resistance,
adipose tissue dysfunction and other factors. Obviously, PCOS is a socially significant
gynecological pathology of early reproductive age, which requires optimization of the
diagnosis and management of such patients from adolescence.
In adolescents, PCOS is diagnosed in the presence of clinical
hyperandrogenism and an irregular menstrual cycle, while ultrasound criteria are not
always reliable. For an individual approach and choice of treatment tactics, it is
extremely important to verify the diagnosis of PCOS in a timely manner, determine the
clinical phenotype and take into account the reproductive plans of the patient.
References
References:
1. Savelyeva G., Sukhikh G., Serov V., Radzinskiy V., Manukhin I. (2019)
Ginekologiya. Natsionalnoye rukovodstvo[Gynecology. National guideline].
Мoscow: GEOTAR-Media. (in Russian)
2. Teede H., Misso M., Costello M. (eds.) (2018) International evidence-based
guideline for the assesstent and management of polycystic ovary syndrome.
3. Adamyan L., Andreyeva E., Absatarova Y., Grigoryan O., Dedov I., Melnichenko
G., Suturina L., Filippov O., Sherementyeva E.,Chernukha G., Yarmolinskaya
M. (2021) Sindrom polikistoznykh yaichnikov. Klinicheskiye rekomendatsii
(protokol lecheniya)[Polycystic ovary syndrome. Clinical guidelines (treatment
protocol)]. Мoscow. (in Russian)
4. Azziz R. (2016) PCOS in 2015: new insights into the genetics of polycystic ovary
syndrome. Nat. Rev. Endocrinol.,vol. 12, no 2, pp. 74–75. doi:
10.1038/nrendo.2015.230.
5. Azziz R. (2016) PCOS in 2015: new insights into the genetics of polycystic ovary
syndrome. Nat. Rev. Endocrinol.,vol. 12, no 2, pp. 74–75. doi:
10.1038/nrendo.2015.230.
6. Lerchbaum E., Schwetz V., Giuliani A., Obermayer-Pietsch B. (2014) Influence of
a positive family history of both type 2 diabetes and PCOS on metabolic and endocrine parameters in a large cohort of PCOS women. Eur. J. Endocrinol.,vol.
170, no 5, pp. 727–739. doi: 10.1530/EJE-13-1035.
7. Panarina O., Rashidova M., Belenkaya L., Trofimova T., Sholokhov L. (2017)
Sovremennyye predstavleniya o patogeneze sindroma polikistoznykh yaichnikov
(obzor literatury) [Modern concepts of the pathogenesis of polycystic ovary
syndrome (literature review)]. Acta Biomedica Scientifi ca,vol. 2, no 4, pp. 9–14.
8. Solopova A., Makatsariya A., Solopova A., Nikiforova O. (2017)
Skleropolikistoznyye yaichniki: sovremennyy vzglyad na problemu [Sclerocystic
ovaries: current approaches to the problem]. Obstetrics. Gynecology.
Reproduction,vol. 11, no 2, pp. 60.
9. Guriyev T. (2010) Sindrom polikistoznykh yaichnikov [Polycystic ovarian
syndrome]. Obstetrics, gynecology and reproduction,vol. 4, no 2, pp. 10–15.
10. Shestakova I., Ryabinkina T. (2015) SPKYa: novyy vzglyad na problemu.
Mnogoobraziye simptomov. differentsialnaya diagnostika i lecheniye SPKYa
[PCOS: a new view of the problem. Multiple symptoms, diff erential diagnosis and
treatment of PCOS]. StatusPraesens, pp. 24.
11. Сhazenbalk G. (2010) Regulation of adiponectin secretion by adipocytes in the
polycystic ovary syndrome: role of tumor necrosis factor-α. J. Clin. Endocrinol.
Metab,vol. 95, no 2, pp. 935–942. doi: 10.1210/jc.2009-1158.
12. Mikhaylova S., Zykova T. (2013) Vitamin D. autoimmunnyye zabolevaniya
shchitovidnoy zhelezy i narusheniya reproduktivnoy funktsii u zhenshchin
[Vitamin D, autoimmune pathology of thyroid gland and reproductive disorders in
women]. Siberian Medical Journal, no 7, pp. 13–17.
13. Teede H.J., Misso M.L., Costello M.F., Dokras A., Laven J., Moran L., Piltonen T.,
Norman R.J.; International PCOS Network (2018) Recommendations from the
international evidence-based guideline for the assessment and management of
polycystic ovary syndrome. Fertil Steril., 110 (3), pp. 364–379.
14. Teede H.J., Misso M.L., Costello M.F., Dokras A., Laven J., Moran L., Piltonen T.,
Norman R.J.; International PCOS Network (2018) Recommendations from the
international evidence-based guideline for the assessment and management of
polycystic ovary syndrome. Fertil Steril., 110 (3), pp. 364–379.
15. Hickey M., Doherty D., Atkinson H., Sloboda D., Franks S., Norman R., Hart R.
(2011) Clinical, ultrasound and biochemical features of polycystic ovary syndrome
in adolescents: implications for diagnosis. Hum Reprod,vol. 26, no 6, pp. 1469–
1477. doi: 10.1093/humrep/der102.
